Vaccine Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Vaccine (Attenuated Vaccine, Inactivated Vaccine, Subunit vaccines, Toxoid Vaccines, DNA Vaccines), By Workflow (Downstream, Upstream), By Application (Human Use, Veterinary), by Region, Country, Segment, and Companies, 2024-2030
The global Vaccine Contract Manufacturing market size is poised to register 11.37% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Vaccine Contract Manufacturing market across By Vaccine (Attenuated Vaccine, Inactivated Vaccine, Subunit vaccines, Toxoid Vaccines, DNA Vaccines), By Workflow (Downstream, Upstream), By Application (Human Use, Veterinary).
The Vaccine Contract Manufacturing Market is experiencing significant growth driven by the increasing demand for vaccines globally and the need for outsourcing manufacturing capabilities to meet production requirements. Key trends shaping its future include the expansion of contract manufacturing organizations (CMOs) offering specialized vaccine production services, the integration of advanced bioprocessing technologies and single-use systems for flexible and scalable manufacturing, and the adoption of quality assurance and regulatory compliance standards to ensure vaccine quality and safety. Moreover, factors such as the growing vaccine pipeline and the emergence of new infectious diseases are expected to drive market growth in 2024 and beyond.
Vaccine Contract Manufacturing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Vaccine Contract Manufacturing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Vaccine Contract Manufacturing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Vaccine Contract Manufacturing industry.
Key market trends defining the global Vaccine Contract Manufacturing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Vaccine Contract Manufacturing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Vaccine Contract Manufacturing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Vaccine Contract Manufacturing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Vaccine Contract Manufacturing industry
Leading Vaccine Contract Manufacturing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Vaccine Contract Manufacturing companies.
Vaccine Contract Manufacturing Market Study- Strategic Analysis Review
The Vaccine Contract Manufacturing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Vaccine Contract Manufacturing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Vaccine Contract Manufacturing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Vaccine Contract Manufacturing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Vaccine Contract Manufacturing market segments. Similarly, Strong end-user demand is encouraging Canadian Vaccine Contract Manufacturing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Vaccine Contract Manufacturing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Vaccine Contract Manufacturing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Vaccine Contract Manufacturing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Vaccine Contract Manufacturing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Vaccine Contract Manufacturing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Vaccine Contract Manufacturing in Asia Pacific. In particular, China, India, and South East Asian Vaccine Contract Manufacturing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Vaccine Contract Manufacturing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Vaccine Contract Manufacturing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Vaccine Contract Manufacturing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Vaccine Contract Manufacturing.
Vaccine Contract Manufacturing Market Company Profiles
The global Vaccine Contract Manufacturing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Ajinomoto Bio-Pharma Services, Catalent, Charles River Laboratories International Inc, CJ CheilJedang Corp, Curia Global, Emergent BioSolutions Inc, Fujifilm Holdings Corp, Gedeon Richter, ICON PLC, IDT Biologika GmbH, Lonza Group AG, Recipharm AB
Recent Vaccine Contract Manufacturing Market Developments
The global Vaccine Contract Manufacturing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Vaccine Contract Manufacturing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Vaccine Type
Attenuated Vaccine
Inactivated Vaccine
Subunit vaccines
Toxoid Vaccines
DNA Vaccines
By Workflow
Downstream
-Fill & Finish Operations
-Analytical & QC studies
-Packaging
Upstream
-Mammalian Expression Systems
-Bacterial Expression Systems
-Yeast Expression Systems
-Baculovirus/Insect Expression Systems
-Others
By Application
Human Use
Veterinary
Geographical Segmentation:
Ajinomoto Bio-Pharma Services
Catalent
Charles River Laboratories International Inc
CJ CheilJedang Corp
Curia Global
Emergent BioSolutions Inc
Fujifilm Holdings Corp
Gedeon Richter
ICON PLC
IDT Biologika GmbH
Lonza Group AG
Recipharm AB
Formats Available: Excel, PDF, and PPT
The Vaccine Contract Manufacturing Market is experiencing significant growth driven by the increasing demand for vaccines globally and the need for outsourcing manufacturing capabilities to meet production requirements. Key trends shaping its future include the expansion of contract manufacturing organizations (CMOs) offering specialized vaccine production services, the integration of advanced bioprocessing technologies and single-use systems for flexible and scalable manufacturing, and the adoption of quality assurance and regulatory compliance standards to ensure vaccine quality and safety. Moreover, factors such as the growing vaccine pipeline and the emergence of new infectious diseases are expected to drive market growth in 2024 and beyond.
Vaccine Contract Manufacturing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Vaccine Contract Manufacturing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Vaccine Contract Manufacturing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Vaccine Contract Manufacturing industry.
Key market trends defining the global Vaccine Contract Manufacturing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Vaccine Contract Manufacturing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Vaccine Contract Manufacturing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Vaccine Contract Manufacturing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Vaccine Contract Manufacturing industry
Leading Vaccine Contract Manufacturing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Vaccine Contract Manufacturing companies.
Vaccine Contract Manufacturing Market Study- Strategic Analysis Review
The Vaccine Contract Manufacturing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Vaccine Contract Manufacturing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Vaccine Contract Manufacturing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Vaccine Contract Manufacturing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Vaccine Contract Manufacturing market segments. Similarly, Strong end-user demand is encouraging Canadian Vaccine Contract Manufacturing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Vaccine Contract Manufacturing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Vaccine Contract Manufacturing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Vaccine Contract Manufacturing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Vaccine Contract Manufacturing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Vaccine Contract Manufacturing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Vaccine Contract Manufacturing in Asia Pacific. In particular, China, India, and South East Asian Vaccine Contract Manufacturing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Vaccine Contract Manufacturing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Vaccine Contract Manufacturing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Vaccine Contract Manufacturing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Vaccine Contract Manufacturing.
Vaccine Contract Manufacturing Market Company Profiles
The global Vaccine Contract Manufacturing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Ajinomoto Bio-Pharma Services, Catalent, Charles River Laboratories International Inc, CJ CheilJedang Corp, Curia Global, Emergent BioSolutions Inc, Fujifilm Holdings Corp, Gedeon Richter, ICON PLC, IDT Biologika GmbH, Lonza Group AG, Recipharm AB
Recent Vaccine Contract Manufacturing Market Developments
The global Vaccine Contract Manufacturing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Vaccine Contract Manufacturing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Vaccine Type
Attenuated Vaccine
Inactivated Vaccine
Subunit vaccines
Toxoid Vaccines
DNA Vaccines
By Workflow
Downstream
-Fill & Finish Operations
-Analytical & QC studies
-Packaging
Upstream
-Mammalian Expression Systems
-Bacterial Expression Systems
-Yeast Expression Systems
-Baculovirus/Insect Expression Systems
-Others
By Application
Human Use
Veterinary
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Ajinomoto Bio-Pharma Services
Catalent
Charles River Laboratories International Inc
CJ CheilJedang Corp
Curia Global
Emergent BioSolutions Inc
Fujifilm Holdings Corp
Gedeon Richter
ICON PLC
IDT Biologika GmbH
Lonza Group AG
Recipharm AB
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Vaccine Contract Manufacturing Market Overview and Key Findings, 2024
1.2 Vaccine Contract Manufacturing Market Size and Growth Outlook, 2021- 2030
1.3 Vaccine Contract Manufacturing Market Growth Opportunities to 2030
1.4 Key Vaccine Contract Manufacturing Market Trends and Challenges
1.4.1 Vaccine Contract Manufacturing Market Drivers and Trends
1.4.2 Vaccine Contract Manufacturing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Vaccine Contract Manufacturing Companies
2. VACCINE CONTRACT MANUFACTURING MARKET SIZE OUTLOOK TO 2030
2.1 Vaccine Contract Manufacturing Market Size Outlook, USD Million, 2021- 2030
2.2 Vaccine Contract Manufacturing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VACCINE CONTRACT MANUFACTURING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Vaccine Type
Attenuated Vaccine
Inactivated Vaccine
Subunit vaccines
Toxoid Vaccines
DNA Vaccines
By Workflow
Downstream
-Fill & Finish Operations
-Analytical & QC studies
-Packaging
Upstream
-Mammalian Expression Systems
-Bacterial Expression Systems
-Yeast Expression Systems
-Baculovirus/Insect Expression Systems
-Others
By Application
Human Use
Veterinary
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Vaccine Contract Manufacturing Market, 2025
5.2 Asia Pacific Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Vaccine Contract Manufacturing Market, 2025
5.5 Europe Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.6 Europe Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Vaccine Contract Manufacturing Market, 2025
5.8 North America Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.9 North America Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Vaccine Contract Manufacturing Market, 2025
5.11 South America Pacific Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.12 South America Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Vaccine Contract Manufacturing Market, 2025
5.14 Middle East Africa Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Vaccine Contract Manufacturing Market Size Outlook and Revenue Growth Forecasts
6.2 US Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Vaccine Contract Manufacturing Industry Drivers and Opportunities
7. VACCINE CONTRACT MANUFACTURING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VACCINE CONTRACT MANUFACTURING COMPANY PROFILES
8.1 Profiles of Leading Vaccine Contract Manufacturing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Ajinomoto Bio-Pharma Services
Catalent
Charles River Laboratories International Inc
CJ CheilJedang Corp
Curia Global
Emergent BioSolutions Inc
Fujifilm Holdings Corp
Gedeon Richter
ICON PLC
IDT Biologika GmbH
Lonza Group AG
Recipharm AB
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Vaccine Contract Manufacturing Market Overview and Key Findings, 2024
1.2 Vaccine Contract Manufacturing Market Size and Growth Outlook, 2021- 2030
1.3 Vaccine Contract Manufacturing Market Growth Opportunities to 2030
1.4 Key Vaccine Contract Manufacturing Market Trends and Challenges
1.4.1 Vaccine Contract Manufacturing Market Drivers and Trends
1.4.2 Vaccine Contract Manufacturing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Vaccine Contract Manufacturing Companies
2. VACCINE CONTRACT MANUFACTURING MARKET SIZE OUTLOOK TO 2030
2.1 Vaccine Contract Manufacturing Market Size Outlook, USD Million, 2021- 2030
2.2 Vaccine Contract Manufacturing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. VACCINE CONTRACT MANUFACTURING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. VACCINE CONTRACT MANUFACTURING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Vaccine Type
Attenuated Vaccine
Inactivated Vaccine
Subunit vaccines
Toxoid Vaccines
DNA Vaccines
By Workflow
Downstream
-Fill & Finish Operations
-Analytical & QC studies
-Packaging
Upstream
-Mammalian Expression Systems
-Bacterial Expression Systems
-Yeast Expression Systems
-Baculovirus/Insect Expression Systems
-Others
By Application
Human Use
Veterinary
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Vaccine Contract Manufacturing Market, 2025
5.2 Asia Pacific Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Vaccine Contract Manufacturing Market, 2025
5.5 Europe Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.6 Europe Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Vaccine Contract Manufacturing Market, 2025
5.8 North America Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.9 North America Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Vaccine Contract Manufacturing Market, 2025
5.11 South America Pacific Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.12 South America Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Vaccine Contract Manufacturing Market, 2025
5.14 Middle East Africa Vaccine Contract Manufacturing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Vaccine Contract Manufacturing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Vaccine Contract Manufacturing Market Size Outlook and Revenue Growth Forecasts
6.2 US Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Vaccine Contract Manufacturing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Vaccine Contract Manufacturing Industry Drivers and Opportunities
7. VACCINE CONTRACT MANUFACTURING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. VACCINE CONTRACT MANUFACTURING COMPANY PROFILES
8.1 Profiles of Leading Vaccine Contract Manufacturing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Ajinomoto Bio-Pharma Services
Catalent
Charles River Laboratories International Inc
CJ CheilJedang Corp
Curia Global
Emergent BioSolutions Inc
Fujifilm Holdings Corp
Gedeon Richter
ICON PLC
IDT Biologika GmbH
Lonza Group AG
Recipharm AB
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
